NeurologyLive® Friday 5 — February 24, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 24, 2023.
This Week on NeurologyLive® — February 20, 2023
Here's some of what is coming soon to NeurologyLive® this week.
CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease
Neurology News Network for the week ending February 18, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — February 17, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 17, 2023.
This Week on NeurologyLive® — February 13, 2023
PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine
Neurology News Network for the week ending February 11, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 10, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 10, 2023.
This Week on NeurologyLive® — February 6, 2023
New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted
Neurology News Network for the week ending February 4, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — February 3, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 3, 2023.
This Week on NeurologyLive® — January 29, 2023
Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab
Neurology News Network for the week ending January 28, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — January 27, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 27, 2023.
This Week on NeurologyLive® — January 23, 2023
COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA
Neurology News Network for the week ending January 21, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — January 20, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 20, 2023.
This Week on NeurologyLive® — January 16, 2023
24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified
Neurology News Network for the week ending January 14, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — January 13, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 13, 2023.
This Week on NeurologyLive® — January 9, 2023
Pimavanserin's Positive Impact on Mortality, Concerns Raised Over Lecanemab Patient Death, FDA Clears Zoom RDL Access System
Neurology News Network for the week ending January 7, 2022. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — January 6, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 6, 2023.
This Week on NeurologyLive® — January 2, 2023
NeurologyLive® Year in Review 2022: Most-Watched Sleep Disorder Expert Interviews
These were the most-watched interviews with experts in sleep disorders that we conducted in 2022, brought to you as part of NeurologyLive®'s Year in Review.
FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold
Neurology News Network for the week ending December 31, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Year in Review 2022: Most-Watched Stroke and Brain Injury Expert Interviews
These were the most-watched interviews with experts in stroke and brain injury that we conducted in 2022, brought to you as part of NeurologyLive®'s Year in Review.
NeurologyLive® Year in Review 2022: Top Stories in Multiple Sclerosis
As part of NeurologyLive®'s Year in Review, take a look at our most-read news in multiple sclerosis in 2022.
NeurologyLive® Year in Review 2022: Most-Listened Mind Moments® Episodes
In 2022, these episodes of the Mind Moments® podcast got the most attention from listeners, with this list brought to you as part of NeurologyLive®'s Year in Review.
NeurologyLive® Year in Review 2022: Most-Watched Neuromuscular Disorder Expert Interviews
These were the most-watched interviews with experts in neuromuscular disorders that we conducted in 2022, brought to you as part of NeurologyLive®'s Year in Review.
NeurologyLive® Year in Review 2022: Top Stories in Movement Disorders
As part of NeurologyLive®'s Year in Review, take a look at the top most-read news in movement disorders in 2022.